Inipharm Competitors and Similar CompaniesClear all

Inipharm's competitors and similar companies include ReviveMed, Edgewise Therapeutics, Xenikos and ALX Oncology.

	Inipharm Inipharm is a biopharmaceutical company that develops treatments for severe liver diseases.	ReviveMed ReviveMed is a company dedicated to discovering therapeutics for metabolic diseases using artificial intelligence technology.	Edgewise Therapeutics Edgewise Therapeutics is a biotechnology company focused on developing therapies for muscle disorders.	Xenikos Xenikos is a clinical-stage biopharmaceutical company.	ALX Oncology ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.
Founding Date	Founding Date 2018	Founding Date 2018	Founding Date 2017	Founding Date 2012	Founding Date 2015
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech healthtech pharma therapy	Tags Healthcare artificial intelligence biotech drug development medical diagnostics oncology	Tags Healthcare biotech healthtech pharma therapy	Tags Healthcare biotech healthtech pharma therapy	Tags Healthcare biotech healthtech oncology pharma therapy
Locations	Locations Bellevue, US HQ San Diego, US	Locations Cambridge, US HQ	Locations Boulder, US HQ	Locations Nijmegen, NL HQ	Locations Burlingame, US HQ Dublin 2, IE
Employees	Employees 12	Employees 7	Employees 11025% increase	Employees 1	Employees 743% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.2 b	Valuation ($) N/A	Valuation ($) 77.5 m
Financial
Net income	Net income N/A	Net income N/A	Net income ($167.8m) (FY, 2025)	Net income N/A	Net income ($101.7m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 35m (over 5 years ago)	Latest funding round $ 1.5m (about 8 years ago)	Latest funding round N/A	Latest funding round $ 30m (almost 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 35m	Total funding raised $ 1.5m	Total funding raised $ 50m	Total funding raised $ 37m	Total funding raised $ 166m